TC Biopharm (Holdings) Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 2476.8%.

Top 13 shareholders own 3.75% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
3.32%	Armistice Capital LLC	105,938	US$151.5k	612%	no data
0.21%	Renaissance Capital Partners Ltd	6,842	US$9.8k	0%	54.5%
0.087%	Tower Research Capital LLC	2,770	US$4.0k	0%	no data
0.06%	Nipro Corporation	1,930	US$2.8k	0%	no data
0.023%	Angela Scott	741	US$1.1k	0%	no data
0.021%	Michael Leek	664	US$949.4	0%	no data
0.016%	Mark Randall	498	US$712.3	0%	no data
0.0033%	Bryan Kobel	105	US$150.3	0%	no data
0.0031%	Kenneth Randall	100	US$143.0	0%	no data
0.0031%	Steward Financial Group, LLC	100	US$143.0	0%	no data
0.0028%	JPMorgan Chase & Co, Private Banking and Investment Banking Investments	89	US$127.5	0%	no data
0.0016%	Wells Fargo & Company, Securities and Brokerage Investments	50	US$71.3	-92.3%	no data
0.00003%	Martin Thorp	1	US$1.4	0%	no data